 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 9 | 1/1 | 返回列表 |
| 查看: 1293 | 回復(fù): 8 | ||
wonboy木蟲 (著名寫手)
|
[求助]
求助USP35 S2 quetiapine fumarate
|
| 如題，請(qǐng)各位大俠幫幫忙，感激不盡，如能搞到EP的資料就更好了，謝謝！ |
回復(fù)此樓» 猜你喜歡
調(diào)劑
已經(jīng)有3人回復(fù)
-
藥學(xué)學(xué)碩326求調(diào)劑
已經(jīng)有0人回復(fù)
-
藥物學(xué)論文潤(rùn)色/翻譯怎么收費(fèi)?
已經(jīng)有78人回復(fù)
-
26年博士申請(qǐng)
已經(jīng)有20人回復(fù)
-
求助 苯磷硫胺JP
已經(jīng)有0人回復(fù)
-
100金幣 阿莫西林克拉維酸鉀片BP藥典中提到的克拉維酸聚合物具體結(jié)構(gòu)式是啥？
已經(jīng)有2人回復(fù)
-
錦州醫(yī)科大學(xué)藥用生物材料（專業(yè)代碼1007Z1）招收調(diào)劑考生
已經(jīng)有0人回復(fù)
-
錦州醫(yī)科大學(xué)藥用生物材料（專業(yè)代碼1007Z1）招收調(diào)劑考生
已經(jīng)有1人回復(fù)
-
膳食補(bǔ)充劑合規(guī)性交流
已經(jīng)有0人回復(fù)
-
26申博自薦
已經(jīng)有9人回復(fù)
-
一志愿浙大藥學(xué)求調(diào)劑
已經(jīng)有0人回復(fù)
tomsunday
銀蟲 (小有名氣)
- 應(yīng)助: 1 (幼兒園)
- 金幣: 724.4
- 帖子: 170
- 在線: 59.1小時(shí)
- 蟲號(hào): 123914
- 注冊(cè): 2005-12-05
- 性別: GG
- 專業(yè): 藥劑學(xué)
【答案】應(yīng)助回帖
★ ★ ★ ★ ★ ★ ★
感謝參與，應(yīng)助指數(shù) +1
癡夷子皮: 金幣+2, 正解，歡迎常來(lái)哦。 2013-04-01 09:53:45
wonboy: 金幣+5, ★有幫助, 貌似JP16的S1和印度藥典2010版有收錄，不過(guò)都沒(méi)辦法查到 2013-04-01 19:42:09
感謝參與，應(yīng)助指數(shù) +1
癡夷子皮: 金幣+2, 正解，歡迎常來(lái)哦。 2013-04-01 09:53:45
wonboy: 金幣+5, ★有幫助, 貌似JP16的S1和印度藥典2010版有收錄，不過(guò)都沒(méi)辦法查到 2013-04-01 19:42:09
|
Not official USP-NF text QUETIAPINE FUMARATE PF LGS# Brand Type of Test Additional Information 37(3) L7 ZORBAX RX-C8 Assay 4.6 mm x 25 cm, 5 µm. 37(3) L7 Symmetry C8 Organic Impurities 3.9 mm x 15 cm, 5 µm. 好像尚未正式出版。 |
2樓2013-04-01 09:50:06
tomsunday
銀蟲 (小有名氣)
- 應(yīng)助: 1 (幼兒園)
- 金幣: 724.4
- 帖子: 170
- 在線: 59.1小時(shí)
- 蟲號(hào): 123914
- 注冊(cè): 2005-12-05
- 性別: GG
- 專業(yè): 藥劑學(xué)
3樓2013-04-01 09:52:46
4樓2013-04-01 11:01:22
wonboy
木蟲 (著名寫手)
- 應(yīng)助: 5 (幼兒園)
- 金幣: 2809.7
- 散金: 394
- 紅花: 11
- 帖子: 1451
- 在線: 264.7小時(shí)
- 蟲號(hào): 565533
- 注冊(cè): 2008-05-29
- 性別: GG
- 專業(yè): 食品科學(xué)基礎(chǔ)
5樓2013-04-01 12:18:28
【答案】應(yīng)助回帖
★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★
wonboy: 金幣+25, ★★★★★最佳答案, 灰常感謝！貌似JP16的S1和印度藥典2010版有收錄，不過(guò)都沒(méi)辦法查到 2013-04-01 19:42:34
癡夷子皮: 金幣+2, 3Q，辛苦了，歡迎常來(lái)哦。 2013-04-02 08:27:40
wonboy: 金幣+25, ★★★★★最佳答案, 灰常感謝！貌似JP16的S1和印度藥典2010版有收錄，不過(guò)都沒(méi)辦法查到 2013-04-01 19:42:34
癡夷子皮: 金幣+2, 3Q，辛苦了，歡迎常來(lái)哦。 2013-04-02 08:27:40
|
Quetiapine Fumarate (C21H25N3O2S)2 · C4H4O4 883.09 Ethanol, 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]-, (E)-2-butenedioate (2:1) (salt); 2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol fumarate (2:1) salt [111974-72-2.]. DEFINITION Quetiapine Fumarate contains NLT 98.0% and NMT 102.0% of (C21H25N3O2S)2 · C4H4O4 , calculated on the dried basis. IDENTIFICATION • A. Infrared Absorption 197K • B. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay. ASSAY • Procedure Buffer: 2.6 g/L of dibasic ammonium phosphate. Adjust with phosphoric acid to a pH of 6.5. Mobile phase: Methanol, acetonitrile, and Buffer (54:7:39) System suitability solution: 1.0 mg/mL of USP Quetiapine System Suitability RS in Mobile phase Standard solution: 0.08 mg/mL of USP Quetiapine Fumarate RS in Mobile phase Sample solution: 0.08 mg/mL of Quetiapine Fumarate in Mobile phase Chromatographic system (See Chromatography 621 , System Suitability.) Mode: LC Detector: UV 230 nm Column: 4.6-mm × 25-cm; 5-µm packing L7 Flow rate: 1.3 mL/min Injection size: 50 µL System suitability Samples: System suitability solution and Standard solution [ NOTE— The relative retention times for quetiapine impurity I and quetiapine are about 0.9 and 1.0, respectively. ] Suitability requirements Resolution: NLT 1.5 between the quetiapine impurity I and quetiapine peaks, System suitability solution Tailing factor: NMT 2.0 for the quetiapine peak, Standard solution Relative standard deviation: NMT 2.0%, Standard soluion Analysis Samples: Standard solution and Sample solution Calculate the percentage of quetiapine fumarate ((C21H25N3O2S)2 · C4H4O4 ) in the portion of Quetiapine Fumarate taken: Result = ( r U / r S ) × ( C S / C U ) × 100 r U = peak response from the Sample solution r S = peak response from the Standard solution C S = concentration of USP Quetiapine Fumarate RS in the Standard solution (mg/mL) C U = concentration of Quetiapine Fumarate in the Sample solution (mg/mL) Acceptance criteria: 98.0%–102.0% on the dried basis OTHER COMPONENTS • Content of Fumaric Acid Sample: 200 mg of Quetiapine Fumarate Titrimetric system (See Titrimetry 541 .) Mode: Direct titration Titrant: 0.1 N tetrabutylammonium hydroxide in methanol/isopropyl alcohol VS Endpoint detection: Potentiometric Blank: 50 mL of dimethylformamide Analysis: Dissolve the Sample in 50 mL of dimethylformamide, and titrate with 0.1 N tetrabutylammonium hydroxide in methanol/isopropyl alcohol VS. Calculate the percentage of fumaric acid (C4H4O4 ) in the portion of the Quetiapine Fumarate taken: Result = [(V B) × N × F × 100]/W V = volume of titrant needed for the Sample (mL) B = volume of titrant needed for the Blank (mL) N = titrant normality (mEq/mL) F = equivalency factor for fumaric acid, 116.07 mg/mEq W = weight of the Sample (mg) Acceptance criteria: 13.0%–13.3% on the dried basis IMPURITIES • Residue on Ignition 281 : NMT 0.1% • Heavy Metals, Method II 231 : NMT 20 ppm • Organic Impurities Buffer: Dissolve 3.3 g of dibasic ammonium phosphate in 900 mL of water. Adjust with phosphoric acid to a pH of 7.0. Dilute with water to 1 L. Solvent mixture: Acetonitrile and methanol (67:33) Solution A: Solvent mixture and Buffer (41:59) Solution B: Solvent mixture and water (80:20) Mobile phase: See Table 1. Return to original conditions, and requilibrate the column. Table 1 Time (min) Solution A (%) Solution B (%) 0 90 10 13 90 10 25 10 90 38 10 90 38.1 90 10 50 90 10 System suitability solution: 1 mg/mL of USP Quetiapine System Suitability RS in Solution A Standard solution: 1 µg/mL of USP Quetiapine Fumarate RS in Solution A Sample solution: 1.0 mg/mL of Quetiapine Fumarate in Solution A Chromatographic system (See Chromatography 621 , System Suitability.) Mode: LC Detector: UV 240 nm Column: 3.9-mm × 15-cm; 5-µm packing L7 Flow rate: 1 mL/min Injection size: 20 µL System suitability Samples: System suitability solution and Standard solution Suitability requirements Resolution: NLT 2.0 between the quetiapine impurity I and quetiapine peaks, System suitability solution Tailing factor: NMT 2.0 for the quetiapine peak, Standard solution Relative standard deviation: NMT 5.0%, Standard solution Analysis Samples: Standard solution and Sample solution Calculate the percentage of any individual impurity in the portion of Quetiapine Fumarate taken: Result = ( r U / r S ) × ( C S / C U ) × (1/F) 100 r U = peak response for each impurity from the Sample solution r S = peak response for quetiapine from the Standard solution C S = concentration of USP Quetiapine Fumarate RS in the Standard solution (mg/mL) C U = concentration of Quetiapine Fumarate in the Sample solution (mg/mL) F = relative response factor (see Table 2) [ NOTE— Disregard if the limit is less than 0.05%. ] Acceptance criteria: See Table 2. Table 2 Name Relative Retention Time Relative Response Factor Acceptance Criteria, NMT (%) Quetiapine impurity Ba 0.5–0.8 1.7 0.15 Quetiapine impurity Gb 0.6 1.7 0.15 Quetiapine impurity Ic 0.9 1.0 0.15 Quetiapine 1.0 — — Any other unknown individual impurity — — 0.10 Total impurities — — 0.3 a 11-(Piperazin-1-yl)dibenzo[b,f][1,4]thiazepine. b Dibenzo[b,f][1,4]thiazepin-11(10H )-one. c 2-[4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl]ethanol. SPECIFIC TESTS • Loss on Drying 731 : Dry a sample to constant weight at 105: it loses NMT 0.5% of its weight. ADDITIONAL REQUIREMENTS • Packaging and Storage: Preserve in well-closed containers, protected from light. Store at room temperature. • USP Reference Standards 11 USP Quetiapine Fumarate RS USP Quetiapine System Suitability RS It contains more than 98% of quetiapine fumarate and each of the following impurities:quetiapine impurity B: 11-(piperazin-1-yl)dibenzo[b,f][1,4]thiazepine; quetiapine impurity G: dibenzo[b,f][1,4]thiazepin-11(10H )-one; and quetiapine impurity I: 2-[4-(dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl]ethanol. 1S (USP35) |
6樓2013-04-01 13:46:49
7樓2013-04-01 13:47:16
8樓2013-04-01 13:48:35
anemone1982
鐵桿木蟲 (著名寫手)
- 應(yīng)助: 0 (幼兒園)
- 金幣: 6880.3
- 帖子: 1602
- 在線: 63.2小時(shí)
- 蟲號(hào): 264116
- 注冊(cè): 2006-07-08
- 性別: GG
- 專業(yè): 藥劑學(xué)
9樓2013-04-01 14:04:19
相關(guān)版塊跳轉(zhuǎn)
我要訂閱樓主 wonboy 的主題更新
| 9 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 一志愿北京化工大學(xué) 070300 學(xué)碩 336分 求調(diào)劑 +7 | vv迷 2026-03-22 | 7/350 |
|
|---|---|---|---|---|
|
|
[考研] 291求調(diào)劑 +8 | hhhhxn.. 2026-03-23 | 8/400 |
|
|
|
[考研] 一志愿中南大學(xué)化學(xué)學(xué)碩0703總分337求調(diào)劑 +5 | niko- 2026-03-22 | 5/250 |
|
|
|
[考研] 384求調(diào)劑 +3 | 子系博 2026-03-22 | 6/300 |
|
|
[考研] 0703化學(xué)求調(diào)劑 +4 | 奶油草莓. 2026-03-22 | 5/250 |
|
|
|
[考研] 一志愿陜師大生物學(xué)071000，298分，求調(diào)劑 +3 | SYA！ 2026-03-23 | 3/150 |
|
|
|
[考研] 上海電力大學(xué)材料防護(hù)與新材料重點(diǎn)實(shí)驗(yàn)室招收調(diào)劑研究生（材料、化學(xué)、電化學(xué)，環(huán)境） +3 | 我愛學(xué)電池 2026-03-23 | 3/150 |
|
|
|
[考研] 0854電子信息求調(diào)劑 324 +3 | Promise-jyl 2026-03-23 | 3/150 |
|
|
|
[考研] 求老師收我 +3 | zzh16938784 2026-03-23 | 3/150 |
|
|
|
[考研] 333求調(diào)劑 +6 | 87639 2026-03-21 | 10/500 |
|
|
|
[考研] 307求調(diào)劑 +11 | 冷笙123 2026-03-17 | 11/550 |
|
|
|
[考研] 318求調(diào)劑 +4 | plum李子 2026-03-21 | 7/350 |
|
|
|
[考研] 求助 +5 | 夢(mèng)里的無(wú)言 2026-03-21 | 6/300 |
|
|
|
[考研] 266求調(diào)劑 +3 | 哇呼哼呼哼 2026-03-20 | 3/150 |
|
|
|
[考研] 268求調(diào)劑 +9 | 簡(jiǎn)單點(diǎn)0 2026-03-17 | 9/450 |
|
|
|
[考研] 南京大學(xué)化學(xué)376求調(diào)劑 +3 | hisfailed 2026-03-19 | 6/300 |
|
|
|
[考研] 295材料求調(diào)劑，一志愿武漢理工085601專碩 +5 | Charlieyq 2026-03-19 | 5/250 |
|
|
|
[考研] 085600材料與化工求調(diào)劑 +6 | 緒幸與子 2026-03-17 | 6/300 |
|
|
|
[考研] 材料，紡織，生物（0856、0710），化學(xué)招生啦 +3 | Eember. 2026-03-17 | 9/450 |
|
|
|
[考博] 26博士申請(qǐng) +3 | 1042136743 2026-03-17 | 3/150 |
|